Cancer of the Cervix

Morita, Kozo

doi:10.1007/978-3-642-60334-1_9

Cited by 6 publications

(2 citation statements)

References 274 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The energy varies from 6 MV to 18 MV mostly depending on patient characteristics and radiotherapy centre energy assortment. Fields arrangement varies from pair of parallel opposite fields, trough "4-field box" to conventional [3][4][5] , arc 3D-conformal (3D-CRT) 6 and intensity modulated techniques (IMRT) 5,[7][8][9] . In patients with bulky disease, positive surgical margin and high tumour grade, intracavitary brachytherapy (ICBT) is used to treat the vaginal cuff and the vaginal cuff with upper third of present vaginal tissue to additional dose of 25-40 Gy.…”

Section: Introductionmentioning

confidence: 99%

Conventional conformal radiotherapy vs intracavitary brachytherapy for the adjuvant postoperative treatment of cervical cancer: A comparative dosimetric study

Milošević¹,

Dabić-Stanković

Stanković³

et al. 2009

ACTA CHIR IUG

View full text Add to dashboard Cite

The referent volume received HDR-ICBT prescribed dose. The maximum ICBT percentage dose to the rectum and urinary bladder was 101% and 106% respectively. In all 3D-CRT plans almost 100% of planning target volume (PTV) was covered by 95% therapy isodose surface. From 12 - 13% of the rectum and 1-3% urinary bladder volume were covered by 100% isodose surface, with the highest maximum dose of 104% and 101%, respectively. Comparison of the PTV dose coverage and the maximum dose to the rectum and urinary bladder for HDR-ICBT and 3D-CRT plans showed no major difference. CONCLUSION; 3D-CRT could be considered as adequate replacement for ICBT in the adjuvant postoperative treatment of the vaginal cuff and upper thi-rd of present vaginal tissue. Time-dose-fractionation pattern for HDR-ICBT may be safely applied for 3D-CRT.

show abstract

Section: Introductionmentioning

confidence: 99%

Conventional conformal radiotherapy vs intracavitary brachytherapy for the adjuvant postoperative treatment of cervical cancer: A comparative dosimetric study

Milošević¹,

Dabić-Stanković

Stanković³

et al. 2009

ACTA CHIR IUG

View full text Add to dashboard Cite

show abstract

“…Cervical cancer is the most common gynecologic cancer in Japan, with an estimated 15 new cases per 100 000 females every year. High dose rate (HDR) intracavitary radiation therapy (ICRT) in combination with external beam radiation therapy (EBRT) has become an acceptable treatment for carcinoma of the cervix 1 …”

Section: Introductionmentioning

confidence: 99%